Alphasimplex Group, LLC Pfizer Inc Transaction History

Alphasimplex Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $564,803 - $837,226	-13,669 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $234,715 - $301,511	-5,980 Reduced 30.43%	13,669 $588,000
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $108,978 - $138,575	-3,256 Reduced 14.22%	19,649 $723,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $110,236 - $129,332	3,472 Added 17.87%	22,905 $841,000
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $585,321 - $710,081	19,433 New	19,433 $635,000
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $1.24 Million - $1.61 Million	-38,287 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $70,964 - $79,676	-1,919 Reduced 4.77%	38,287 $1.66 Billion
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $1.51 Million - $1.66 Million	40,206 New	40,206 $0

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Alphasimplex Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Alphasimplex Group, LLC with notifications on news.